Developability of Biotherapeutics
总篇数：11
- 2019/01/03 【0】生物治疗学的可发展性前言
- 2019/01/06 【1】计算在生物药物开发中的应用
- 2019/01/24 【2】生物模态优化的计算方法
- 2019/01/29 【3】理解，预测和减轻翻译后物理化学修饰（包括聚集）对生物制药药品稳定性的影响
- 2019/01/01 【4】生物治疗药物的临床前免疫原性风险评估(Preclinical Immunogenicity Risk Assessement of Biotherapeutics)
- 2019/02/01 【5】机械药代动力学-药效学模型在生物制剂开发中的应用(Application of Mechanistic Pharmacokinetic–Pharmacodynamic Modeling toward the Development of Biologics)
- 2019/03/19 【6】高浓度生物制药药物输送的挑战--建模视角(Challenges in High- Concentration Biopharmaceutical Drug Delivery ,A Modeling Perspective)
- 2019/03/27 【7】评估生物制药候选物可开发性的最佳实践(Best Practices in Assessment of Developability of Biopharmaceutical Candidates)
- 2019/04/02 【8】生物制药行业治疗性蛋白质候选药物可开发性评估的最佳实践(Best Practices in Developability Assessments of Therapeutic Protein Candidates in the Biopharmaceutical Industry)
- 2019/04/16 【9】评估生物制药候选物可开发性的最佳实践2(Best Practices in Assessment of Developability of Biopharmaceutical Candidates)
- 2019/04/20 【10】可开发性评估工作流程降低生物制药开发风险(Developability Assessment Workflows to De-Risk Biopharmaceutical Development)